Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Witnesses Urge Congress to Boost Aging Research, Develop FDA Pathways and Expand Biomarker Trials
Summary
Scientists at a Senate hearing said aging biology research is at a turning point and urged increased NIH funding, clearer FDA regulatory guidance for aging-targeted therapies, and investment in biomarkers to speed trials and translation.
Dr. Eric Verdin, president and CEO of the Buck Institute for Research on Aging, told the Senate Special Committee on Aging that aging is ‘‘the greatest risk factor’’ for chronic diseases and that the field is at an inflection point. Verdin urged Congress to increase NIH funding for molecular aging research and to support work that translates laboratory findings into human applications.
‘‘The science is at a turning point,’’ Verdin said. He recommended development of validated…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
